AI Verdict
ABBV has stronger fundamentals based on our AI analysis.
ABBV vs CVS Fundamental Comparison
| Metric | ABBV | CVS |
|---|---|---|
| Revenue | $15.0B | $100.4B |
| Net Income | $695.0M | $2.9B |
| Net Margin | 4.6% | 2.9% |
| ROE | N/A | 3.8% |
| ROA | 0.5% | 1.2% |
| Current Ratio | 0.80x | 0.87x |
| Debt/Equity | N/A | 0.78x |
| EPS | $0.39 | $2.30 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs CVS: Frequently Asked Questions
Is ABBV or CVS the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABBV has stronger fundamentals. ABBV is graded C (78% confidence) while CVS is graded C (75% confidence). This is not investment advice.
How does ABBV compare to CVS fundamentally?
AbbVie Inc. has ROE of N/A vs CVS HEALTH Corp's 3.8%. Net margins are 4.6% vs 2.9% respectively.
Which stock pays higher dividends, ABBV or CVS?
ABBV has a dividend yield of N/A or no dividend while CVS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or CVS for long term?
For long-term investing, consider that ABBV has a C grade with 78% confidence, while CVS has a C grade with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs CVS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs CVS, the AI consensus favors ABBV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.